St. Jude Medical, a US-based medical device company, has enrolled the first patient for the EnligHTN III trial. During the study, the safety and performance of the second-generation EnligHTN Renal Denervation System in patients with ...
pSivida has announced the availability of the sustained release pharmaceutical product indicated for the treatment of chronic diabetic macular edema (DME), Iluvien, in Germany. Alimera Sciences, pSivida's licensee, has reported the ...
Tags: pSivida Iluvien, Medicine
Lithera has announced the treatment of first patient with LIPO-202 (Salmeterol Xinafoate for Injection) in the Phase IIb RESET trial. LIPO-202 is an injectable pharmaceutical designed to produce aesthetic reduction of subcutaneous ...
Tags: pharmaceutical, drug, medical
St. Jude Medical has implanted the first patient in a clinical study of its Amplatzer Cardiac Plug (ACP) device, designed for the prevention of stroke in patients with non-valvular atrial fibrillation (AF). The self-expanding occlusion ...
Tags: St.Jude Medical, clinical study, ACP device
Cohera Medical has treated the first patient in a US no-drain clinical study of its TissuGlu Surgical Adhesive, designed for use during large flap surgeries such as abdominoplasty (tummy tuck). The CE-marked internal surgical adhesive ...
Tags: Cohera Medical, no-drain clinical study, TissuGlu Surgical Adhesive
St Jude Medical has treated the first patient with 25 mm Portico Transcatheter aortic heart valve using the transfemoral delivery system in its ongoing non-randomized, multi-center European trial. Made of bovine pericardial tissue, the 25 ...
Tags: Portico aortic heart valve, Medical, minimally invasive device
Velomedix has completed enrollment of the first patient in Velocity clinical study of its rapid therapeutic hypothermia system for treating acute myocardial infarction (AMIs or heart attacks). Using a peritoneal-based approach, the ...
Tags: Velomedix, Velocity clinical study, rapid therapeutic hypothermia system
St Jude Medical has enrolled the first patient in EnligHTN II trial of its multi-electrode renal denervation technology for treating patients with drug-resistant hypertension. The CE-marked EnligHTN renal denervation system, which ...
Tags: EnligHTN II trial, Medical, drug resistant hypertension
Covidien has completed enrolling the first patient in SWIFT PRIME trial of its Solitaire FR Revascularisation device, designed to restore blood flow, administer medical therapy as well as retrieve clot in patients with acute ischemic ...
Tags: Covidien, patient, SWIFT PRIME trial
Medtronic has completed enrolling the first patient in MIRACLE EF clinical trial, designed to evaluate the effectiveness of its Consulta cardiac resynchronization therapy-pacemaker (CRT-P) in treating symptomatic heart failure patients with ...
Tags: Medtronic, MIRACLE EF, trial, CRT-P
CardioKinetix has completed enrolling the first patient in PARACHUTE IV trial of its Parachute ventricular partitioning device for treating heart failure patients. The minimally invasive device is deployed into the left ventricle to ...
Svelte Medical Systems has treated the first patient in the ACES (Acrobat Coronary stent system effectiveness European Study) clinical trial. ACES is a randomized, controlled study to show the clinical benefit and utilization of the ...
Tags: Svelte Medical Systems, clinical trial, ACES, company news
Svelte Medical Systems has treated the first patient in a randomized, controlled study using its fixed-wire based system, designed for treating patients with coronary artery lesions. The low profile Svelte Acrobat Integrated Delivery ...
Tags: Svelte Medical Systems, fixed wire based system, coronary artery lesions
Global medical device company St Jude Medical has enrolled the first patient in its ILUMIEN I observational clinical study. The objective of the study is to determine that an intravascular imaging technology, Optical Coherence Tomography ...
University Medical Center Groningen (UMCG) has treated the first patient using its RePneu lung volume reduction coil (LVRC), designed for relieving breathing difficulty in patients with severe emphysema, in RENEW pivotal trial. The ...